Abiopharma

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-04-02 <b>AccNo:</b> 0001918704-26-009087 <b>Size:</b> 763 KB

Change - Announcement of Cessation: Change - Announcement of Cessation

Merck Announces Initiation of Pivotal Phase 2b/3 Trial Evaluating MK-8748 (Tiespectus), an Investigational Bispecific Tie2 Agonist/VEGF Inhibitor, for the Treatment of Neovascular Age-Related Macular Degeneration

SKEENA RESOURCES LIMITED COMMON SHARES (SKE) Files Form 6-K

PHARVARIS N.V. (PHVS) Files Form 6-K

Pharvaris Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Skeena Gold & Silver Announces Pricing of US$750 Million Senior Secured Notes Offering to Refinance Former Project Financing and to Fund Partial Buyback of Existing Gold Stream

Merck Announces Initiation of Pivotal Phase 2b/3 Trial Evaluating MK-8748 (Tiespectus), an Investigational Bispecific Tie2 Agonist/VEGF Inhibitor, for the Treatment of Neovascular Age-Related Macular Degeneration

New Form 424B2 - UBS AG <b>Filed:</b> 2026-04-02 <b>AccNo:</b> 0001839882-26-018797 <b>Size:</b> 703 KB

Asset Acquisitions and Disposals: PROPOSED ACQUISITION OF 100% SHARES OF COOKING ART INDUSTRIES PTE LTD

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-04-02 <b>AccNo:</b> 0001918704-26-009086 <b>Size:</b> 470 KB

Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s): Disclosure of Interest / Changes in Interest of Substantial Shareholder

BANK OF NOVA SCOTIA (BNS) Files Form 6-K

BRIGHTSTAR LOTTERY PLC (BRSL) Files Form 6-K

(99% Positive) ESAB CORP (ESAB) Announces Business Combination